Abstract
Protein kinases play pivotal roles in almost all signal transduction pathways in eukaryotic cells (1–4) and are implicated in most major human diseases, including atherosclerosis and associated vasculoproliferative disorders of arteries such as restenosis and graft stenosis (5). Several hundred distinct kinases have already been molecularly cloned, and it is likely that as a result of new information generated through large-scale genome sequencing projects this number will increase. Despite this flood of information, and with several important exceptions, there is a relative lack of knowledge regarding the identity of kinases specifically expressed in vascular tissues or cells and more particularly, it remains unclear how the expression of kinases alters in cardiovascular disease states. The first step in approaching this question is to identify the repertoire of kinases present in vascular tissues and cells. The protein tyrosine kinase (PTK) receptors for several polypeptide growth factors, including platelet-derived growth factor (PDGF), insulin-like growth factor-I (IGF-I) and basic fibroblast growth factor (bFGF) have been implicated in neo-intimal and atherosclerotic disease (5). Apart from these and a few other exceptions, surprisingly little is known regarding the patterns of expression of specific PTKs or other kinases in neo-intima formation. The use of anti-phosphotyrosine antibodies, selective tyrosine kinase inhibitors and kinase-specific antibodies is limited.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vandenberger, P., Hunter, T., and Lindberg, R. A. (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10, 251–337.
Hanks, S. K. and Hunter, T. (1995) Protein kinases, the eukaryotic protein kinase superfamily-kinase (catalytic) domain structure and classification. FASEB J. 9, 576–596.
Hanks, S. K., Quinn, A. M., and Hunter, T. (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domain. Science 241, 42–52.
Hanks, S. K. and Quinn, A. M. (1991) Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38–61.
Ross, R. (1993) The Pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809.
Wilks, A. F. (1989) Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 1603–1607.
Wilks, A. F. (1991) Cloning members of the protein-tyrosine kinase family using polymerase chain reaction. Methods Enzymol. 200, 533–545.
Hovens, C. M., Stacker, S. A., Andres, A-C., Harpur, A. G., Ziemiecki, A., and Wilks, A. F. (1992) RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs. Proc. Natl. Acad. Sci. USA 89, 11,818–11,822.
Shanahan, C. M., Weissberg, P. L., and Metcalfe, J. C. (1993) Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 73, 193–204.
Thomas M. R. (1994) Simple, effective cleanup of DNA ligation reactions prior to electro-transformation of E. coli. Biotechniques 16, 988–990.
Sanger, F., Nicklen, S., and Coulson, A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463–5467.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press.
Sasaki, H., Nagura, K., Ishino, M., Tobioka, H., Kotani, K., and Sasaki, T. (1995) Cloning and characterisation of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 271, 21,206–21,219.
Valverde, A. M., Sinnett-Smith, J., Van Lint, J., and Rozengurt, E. (1994) Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. USA 91, 8572–8576.
Johannes, F-J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994) PKCμ is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 269, 6140–6148.
Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487–493.
Herren, B., Raines, E. W., and Ross, R. (1997) Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J. 11, 173–180.
Lhotak, V., Greer, P., Letwin, K., and Pawson, T. (1991) Characterisation of ELK, a brain-specific receptor protein tyrosine kinase. Mol. Cell. Biol. 11, 2496–2502.
Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., and Parsons, J. T. (1992) pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89, 5192–5196.
Mead, D. A., Pey, N. K., Herrnstadt, C., Marcil, R. A., and Smith, L. M. (1991) A universal method for the direct cloning of polymerase chain reaction-amplified nucleic acid. Bio-Technology 9, 657.
McMurray, H., Parrott, D. P., and Bowyer, D. E. (1991) A standardised method of culturing aoric explants suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. Atherosclerosis 86, 227–237.
Southgate, K. M., Davies, M., Booth, R. F. G., and Newby, A. C. (1992) Involvement of extracellular matrix-degrading metalloproteinases in rabbit smooth muscle cell proliferation. Biochem. J. 288, 93–99.
Sheen, J-Y. and Seeds, B. (1988) Electrolyte gradient gels for DNA sequencing. BioTechniques 6, 942–944.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Zachary, I., Servos, S., Herren, B. (1999). Identification of Novel Protein Kinases in Vascular Cells. In: Baker, A.H. (eds) Vascular Disease. Methods in Molecular Medicine™, vol 30. Humana Press. https://doi.org/10.1385/1-59259-247-3:111
Download citation
DOI: https://doi.org/10.1385/1-59259-247-3:111
Publisher Name: Humana Press
Print ISBN: 978-0-89603-731-1
Online ISBN: 978-1-59259-247-0
eBook Packages: Springer Protocols